Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Chong, Yong S (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C514S279000, C514S299000
Reexamination Certificate
active
07928120
ABSTRACT:
The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
REFERENCES:
patent: 3989704 (1976-11-01), Houlihan et al.
patent: 4036964 (1977-07-01), Buckle et al.
patent: 4260611 (1981-04-01), Bartmann et al.
patent: 4559403 (1985-12-01), Bruderer et al.
patent: 4584379 (1986-04-01), Wagner
patent: 4673682 (1987-06-01), Konz et al.
patent: 4822800 (1989-04-01), Faltico et al.
patent: 4952588 (1990-08-01), Glamkowski et al.
patent: 4966906 (1990-10-01), Glamkowski et al.
patent: 5620995 (1997-04-01), Weidmann et al.
patent: 5658933 (1997-08-01), Weidmann et al.
patent: 5719164 (1998-02-01), Weidmann et al.
patent: 6093730 (2000-07-01), Weidmann et al.
patent: 6319931 (2001-11-01), Kroemer et al.
patent: 6358973 (2002-03-01), Napoletano et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6369053 (2002-04-01), Yuan et al.
patent: 6762318 (2004-07-01), Kodra et al.
patent: 6777425 (2004-08-01), Burli et al.
patent: 6903114 (2005-06-01), Backstrom et al.
patent: 7208601 (2007-04-01), Majalli et al.
patent: 7248053 (2007-07-01), Houldsworth
patent: 7294457 (2007-11-01), Kukolj et al.
patent: 7323475 (2008-01-01), Arend et al.
patent: 2003/0153503 (2003-08-01), Klaus et al.
patent: 2003/0176317 (2003-09-01), Guenzler-Pukall et al.
patent: 2004/0204356 (2004-10-01), Guenzler-Pukall et al.
patent: 2004/0235082 (2004-11-01), Fourney et al.
patent: 2005/0020487 (2005-01-01), Klaus et al.
patent: 2006/0035965 (2006-02-01), Dalton et al.
patent: 2006/0178316 (2006-08-01), Klaus et al.
patent: 2006/0183695 (2006-08-01), Klaus et al.
patent: 2006/0199836 (2006-09-01), Turtle et al.
patent: 2006/0217416 (2006-09-01), Arend et al.
patent: 2006/0251638 (2006-11-01), Guenzler-Pukall
patent: 2006/0258660 (2006-11-01), Guenzler-Pukall et al.
patent: 2006/0270699 (2006-11-01), Guenzler-Pukall et al.
patent: 2006/0276477 (2006-12-01), Klaus et al.
patent: 2007/0004627 (2007-01-01), Seeley et al.
patent: 2007/0155784 (2007-07-01), Arend et al.
patent: 2007/0185159 (2007-08-01), Arend et al.
patent: 2007/0292433 (2007-12-01), Seeley et al.
patent: 2007/0293575 (2007-12-01), Seeley et al.
patent: 2008/0004309 (2008-01-01), Deng et al.
patent: 2134866 (1995-05-01), None
patent: 532466 (1993-03-01), None
patent: 0650960 (1994-09-01), None
patent: 0650961 (1994-10-01), None
patent: 626178 (1994-11-01), None
patent: 706795 (1996-04-01), None
patent: 0911340 (1999-04-01), None
patent: 1 676 834 (2006-07-01), None
patent: A-H07-224039 (1995-08-01), None
patent: A-H07-228571 (1995-08-01), None
patent: A-H11-302257 (1999-11-01), None
patent: WO 96/18616 (1996-06-01), None
patent: WO 98/50343 (1998-11-01), None
patent: WO 98/50346 (1998-11-01), None
patent: WO 01/58892 (2001-08-01), None
patent: WO 02/070510 (2002-09-01), None
patent: WO 02/074981 (2002-09-01), None
patent: WO 02/100832 (2002-12-01), None
patent: WO 02/101073 (2002-12-01), None
patent: WO 03/007945 (2003-01-01), None
patent: WO 03/010141 (2003-02-01), None
patent: WO 03/014377 (2003-02-01), None
patent: WO 03/049686 (2003-06-01), None
patent: WO 03/080566 (2003-10-01), None
patent: WO 2004/108681 (2004-12-01), None
patent: WO 2005/009962 (2005-02-01), None
patent: WO 2005/014533 (2005-02-01), None
U.S. Appl. No. 11/495,118, filed Jul. 28, 2006, Guenzler-Pukall et al.
U.S. Appl. No. 11/406,484, filed Apr. 17, 2006, Klaus et al.
U.S. Appl. No. 12/015,275, filed Jan. 16, 2008, Arend et al.
Bickel et al.Hepatology, 28:404-411 (1998).
Cockman et al.,J. Biol. Chem., 275:25733-25741 (2000).
Franklin et al.,Biochem J., 353:333-338 (2000).
Franklin, et al. “Approaches to the design of anti-fibrotic drugs”Biochem. Soc. Trans. 19(4): 812-815 (1991).
Friedman et al.Proc. Natl. Acad. Sci. USA, 97:4736-4741 (2000).
Iliopoulus et al.,Proc. Natl. Acad. Sci. USA, 93:10595-10599 (1996).
Ivan, et al. “HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing”,Science, 292:464-468.
Jaakkola et al. (2001), “Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation,”Science292 (5516):468-472.
Jiang et al.,J. Biol. Chem., 271:17771-17778 (1996).
Kivirikko et al.Matrix Biol., 16:357-368 (1998).
Lando, et al. “Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation”,Eur.J. Biochem, 270:781-790 (2003).
Majamaa et al.Biochem J., 229:127-133 (1985).
Majamaa et al.Eur. J. Biochem., 138:239-245 (1984).
Maxwell et al.,Nature, 399:271-275 (1999).
Richard, et al, “Nonhypoxic Pathway Mediates the Induction of Hypoxia-inducible Factor 1α in Vascular Smooth Muscle Cells”,J. Biol. Chm, 275:26765-26771 (2000).
Safran, et al. “HIF hydroxylation and the mammalian oxygen-sensing pathway”J. Clin. Invest. 111(6):779-783 (2003).
Sandau, et al. “Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the P1 3K Pathway”Biochem. Biophys. Res. Commun., 278:263-267(2000).
Sato et al. “Stability and Physicochemical Properties of Viracept Tablets”Antibiotics and Chemotherapy14(9):1589-1592 (1998)—English Translation Not Available.
Sodhi, et al. “MAPK and Akt Act Cooperatively but Independently on Hypoxia Inducible Factor-1α inrasV12 Unpregulation of VEGF”Biochem.Biophys. Res.Commun., 287:292-300 (2001).
Sutter et al.,Proc. Natl. Acad. Sci. USA, 97:4748-4753 (2000).
Tacchini, et al. “Hepatocyte growth factor signaling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells”Carcinogenesis, 22:1363-1371 (2001).
Tanimoto et al.,EMBO J, 19:4298-4309 (2000).
Arend Michael
Deng Shaojiang
Flippin Lee A.
Ho Wen-Bin
Turtle Eric D.
Chong Yong S
Fibrogen Inc.
Foley & Lardner LLP
LandOfFree
Cyanoisoquinoline compounds and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyanoisoquinoline compounds and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanoisoquinoline compounds and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712009